Metabolic Syndrome and Its Characteristics among Reproductive-Aged Women with Polycystic Ovary Syndrome: A Cross-sectional Study in Northwest Iran

被引:0
|
作者
Tabrizi, Fatemeh Pourteymour Fard [1 ]
Alipoor, Beitollah [2 ]
Sadaghiani, Mahzad Mehrzad [3 ]
Ostadrahimi, Alireza [2 ]
Mahdavi, Aida Malek [2 ]
机构
[1] Tabriz Univ Med Sci, Nutr Res Ctr, Tabriz, Iran
[2] Tabriz Univ Med Sci, Sch Nutr, POB 5166614711, Tabriz, Iran
[3] Tabriz Univ Med Sci, Alzahra Hosp, Infertil & IVF Ctr, Tabriz, Iran
关键词
Metabolic Syndrome; ATP III Criteria; Polycystic Ovary Syndrome;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: Metabolic syndrome (MetS) is a clustering of factors known to increase the risk for cardiovascular disease (CVD) and diabetes mellitus. Polycystic ovary syndrome (PCOS), the most common endocrine disorder among reproductive-aged women, is also closely linked to MetS. Limited information is available pertaining to the prevalence of MetS in Iranian PCOS women; therefore this study assesses the frequency of MetS and its components among PCOS women from Tabriz, Iran. Materials and Methods: In this cross-sectional study, we evaluated a total of 200 women with PCOS who referred to the only specialty and subspecialty gynecological center in Northwestern Iran. PCOS was diagnosed according to Rotterdam criteria. This study defined clinical and biochemical parameters for MetS by the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria. Statistical analyses were performed with descriptive-analytical methods using SPSS software version 16. Results: MetS was identified in 39.5% of PCOS women. The frequencies of individual components of MetS among studied subjects were: high-density lipoprotein cholesterol level (HDL-C)<50 mg/dL (99.5%), waist circumference(WC) >= 88cm (65%), triglycerides (TG) >= 150 mg/dL(98%), and blood ressure >= 130/ 85 mmHg(34%). There were no fasting glucose concentrations >= 110 mg/dL. The frequency of MetS increased with body mass index (BMI) as follows: normal (5.4%), overweight (41.5%) and obese (85.7%) women (p<0.0001). Conclusion: The PCOS women in this study had a high frequency of MetS and its individual components, particularly decreased HDL-C and increased triglyceride levels. These data can useful for lifestyle modification programs.
引用
收藏
页码:244 / 249
页数:6
相关论文
共 50 条
  • [1] Metabolic characteristics of different phenotypes in reproductive-aged women with polycystic ovary syndrome
    Wen, Xinling
    Wang, Li
    Bai, E.
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [2] Endometrial neoplasia in reproductive-aged Thai women with polycystic ovary syndrome
    Indhavivadhana, Suchada
    Rattanachaiyanont, Manee
    Wongwananuruk, Thanyarat
    Techatraisak, Kitirat
    Rayasawath, Nana
    Dangrat, Chongdee
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2018, 142 (02) : 170 - 175
  • [3] Hypertension in Reproductive-Aged Women With Polycystic Ovary Syndrome and Association With Obesity
    Joham, Anju E.
    Boyle, Jacqueline A.
    Zoungas, Sophia
    Teede, Helena J.
    AMERICAN JOURNAL OF HYPERTENSION, 2015, 28 (07) : 847 - 851
  • [4] Asthma in reproductive-aged women with polycystic ovary syndrome and association with Obesity
    Htet, Thaw Dar T. H.
    Teede, Helena H. T.
    de Courten, Barbora Bd C.
    Lexton, Deborah D. L.
    Moran, Lisa L. M.
    Joham, Anju A. J.
    CLINICAL ENDOCRINOLOGY, 2017, 86 : 19 - 19
  • [5] Asthma in reproductive-aged women with polycystic ovary syndrome and association with obesity
    Htet, Thaw D.
    Teede, Helena J.
    de Courten, Barbora
    Loxton, Deborah
    Real, Francisco G.
    Moran, Lisa J.
    Joham, Anju E.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (05)
  • [6] Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study
    Chan, Jessica L.
    Kar, Sujata
    Vanky, Eszter
    Morin-Papunen, Laure
    Piltonen, Terhi
    Puurunen, Johanna
    Tapanainen, Juha S.
    Maciel, Gustavo Arantes Rosa
    Hayashida, Sylvia Asaka Yamashita
    Soares, Jose Maria, Jr.
    Baracat, Edmund Chada
    Mellembakken, Jan Roar
    Dokras, Anuja
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 217 (02) : 189.e1 - 189.e8
  • [7] Metabolic Syndrome and Insulin Resistance Syndrome among Infertile Women with Polycystic Ovary Syndrome: A Cross-Sectional Study from Central Vietnam
    Minh Tam Le
    Vu Quoc Huy Nguyen
    Quang Vinh Truong
    Dinh Duong Le
    Viet Nguyen Sa Le
    Ngoc Thanh Cao
    ENDOCRINOLOGY AND METABOLISM, 2018, 33 (04) : 447 - 458
  • [8] Prevalence of polycystic ovary syndrome in reproductive-aged women with type 2 diabetes
    Amini, Massoud
    Horri, Negar
    Farmani, Mahboubeh
    Haghighi, Sassan
    Sattari, Ghoshtasb
    Pornaghshband, Zahra
    Aminorroaya, Ashraf
    GYNECOLOGICAL ENDOCRINOLOGY, 2008, 24 (08) : 423 - 427
  • [9] Body Fat Distribution in Thai Reproductive-Aged Polycystic Ovary Syndrome Women Compared with Non-Polycystic Ovary Syndrome Women
    Wongwananuruk, Thanyarat
    Kongcharoensukying, Arisa
    Pramyothin, Pornpoj
    Indhavivadhana, Suchada
    Tanmahasamut, Prasong
    Rattanachaiyanont, Manee
    Techatraisak, Kitirat
    Angsuwathana, Surasak
    Sa-ngaareekul, Nutchaya
    Pingkul, Nichamon
    Chantrapanichkul, Panicha
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2024, 51 (02):
  • [10] The Utility of Metformin Therapy in Reproductive-Aged Women with Polycystic Ovary Syndrome (PCOS)
    Nathan, Nisha
    Sullivan, Shannon D.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2014, 15 (01) : 70 - 83